Literature DB >> 18332878

The genetics of bipolar disorder: genome 'hot regions,' genes, new potential candidates and future directions.

A Serretti1, L Mandelli.   

Abstract

Bipolar disorder (BP) is a complex disorder caused by a number of liability genes interacting with the environment. In recent years, a large number of linkage and association studies have been conducted producing an extremely large number of findings often not replicated or partially replicated. Further, results from linkage and association studies are not always easily comparable. Unfortunately, at present a comprehensive coverage of available evidence is still lacking. In the present paper, we summarized results obtained from both linkage and association studies in BP. Further, we indicated new potential interesting genes, located in genome 'hot regions' for BP and being expressed in the brain. We reviewed published studies on the subject till December 2007. We precisely localized regions where positive linkage has been found, by the NCBI Map viewer (http://www.ncbi.nlm.nih.gov/mapview/); further, we identified genes located in interesting areas and expressed in the brain, by the Entrez gene, Unigene databases (http://www.ncbi.nlm.nih.gov/entrez/) and Human Protein Reference Database (http://www.hprd.org); these genes could be of interest in future investigations. The review of association studies gave interesting results, as a number of genes seem to be definitively involved in BP, such as SLC6A4, TPH2, DRD4, SLC6A3, DAOA, DTNBP1, NRG1, DISC1 and BDNF. A number of promising genes, which received independent confirmations, and genes that have to be further investigated in BP, have been also systematically listed. In conclusion, the combination of linkage and association approaches provided a number of liability genes. Nevertheless, other approaches are required to disentangle conflicting findings, such as gene interaction analyses, interaction with psychosocial and environmental factors and, finally, endophenotype investigations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332878     DOI: 10.1038/mp.2008.29

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  53 in total

Review 1.  Uncovering the roles of rare variants in common disease through whole-genome sequencing.

Authors:  Elizabeth T Cirulli; David B Goldstein
Journal:  Nat Rev Genet       Date:  2010-06       Impact factor: 53.242

2.  Gene expression and genetic variation data implicate PCLO in bipolar disorder.

Authors:  Kwang H Choi; Brandon W Higgs; Jens R Wendland; Jonathan Song; Francis J McMahon; Maree J Webster
Journal:  Biol Psychiatry       Date:  2010-12-24       Impact factor: 13.382

3.  Dual regulation of G proteins and the G-protein-activated K+ channels by lithium.

Authors:  Isabella Farhy Tselnicker; Vladimir Tsemakhovich; Ida Rishal; Uri Kahanovitch; Carmen W Dessauer; Nathan Dascal
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

4.  Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.

Authors:  Freja Herborg; Thorvald F Andreassen; Frida Berlin; Claus J Loland; Ulrik Gether
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

5.  Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1.

Authors:  Hong Chang; Lingyi Li; Tao Peng; Maria Grigoroiu-Serbanescu; Sarah E Bergen; Mikael Landén; Christina M Hultman; Andreas J Forstner; Jana Strohmaier; Julian Hecker; Thomas G Schulze; Bertram Müller-Myhsok; Andreas Reif; Philip B Mitchell; Nicholas G Martin; Sven Cichon; Markus M Nöthen; Stéphane Jamain; Marion Leboyer; Frank Bellivier; Bruno Etain; Jean-Pierre Kahn; Chantal Henry; Marcella Rietschel; Xiao Xiao; Ming Li
Journal:  Mol Neurobiol       Date:  2016-08-25       Impact factor: 5.590

6.  Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia.

Authors:  Hader A Mansour; Michael E Talkowski; Joel Wood; Kodavali V Chowdari; Lora McClain; Konasale Prasad; Debra Montrose; Andrea Fagiolini; Edward S Friedman; Michael H Allen; Charles L Bowden; Joseph Calabrese; Rif S El-Mallakh; Michael Escamilla; Stephen V Faraone; Mark D Fossey; Laszlo Gyulai; Jennifer M Loftis; Peter Hauser; Terence A Ketter; Lauren B Marangell; David J Miklowitz; Andrew A Nierenberg; Jayendra Patel; Gary S Sachs; Pamela Sklar; Jordan W Smoller; Nan Laird; Matcheri Keshavan; Michael E Thase; David Axelson; Boris Birmaher; David Lewis; Tim Monk; Ellen Frank; David J Kupfer; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Bipolar Disord       Date:  2009-11       Impact factor: 6.744

7.  Strategies to find candidate genes for bipolar disorder.

Authors:  Chi-Un Pae
Journal:  Psychiatry Investig       Date:  2009-12-31       Impact factor: 2.505

8.  HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.

Authors:  Taro Kishi; Reiji Yoshimura; Tsuyoshi Kitajima; Tomo Okochi; Takenori Okumura; Tomoko Tsunoka; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Hiroshi Naitoh; Jun Nakamura; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2009-11-24       Impact factor: 3.843

9.  Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.

Authors:  Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

10.  Inducible gene manipulations in serotonergic neurons.

Authors:  Tillmann Weber; Gerald Böhm; Elke Hermann; Günther Schütz; Kai Schönig; Dusan Bartsch
Journal:  Front Mol Neurosci       Date:  2009-11-06       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.